Evidence map›Paper›PMID 40188335›Full record

ArticleMalaria journal2025

Asymptomatic malaria reservoirs are the last challenge in the elimination in Cambodia.

Dyna Doum, David J McIver, Ingrid Chen, Vanney Keo, Siv Sovannaroth, Dysoley Lek, Joanne M Cunningham, Diane D Lovin, Nicholas W Daniel, Molly Quan and 3 more

Abstract read
In one paragraph

Article in Malaria journal, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed.

  1. Article
  2. Article
  3. Frequent and genetically diverseResearch square · 2026
    Article
  4. Evaluation ofiScience · 2025
    Article
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors.

Dyna DoumMalaria Elimination Initiative, Institute for Global Health Sciences, University of California, San Francisco, USA. dynadoum@gmail.com.
David J McIverMalaria Elimination Initiative, Institute for Global Health Sciences, University of California, San Francisco, USA.
Ingrid ChenMalaria Elimination Initiative, Institute for Global Health Sciences, University of California, San Francisco, USA.
Vanney KeoHealth Forefront Organization, Phnom Penh, Cambodia.
Siv SovannarothNational Center for Parasitology, Entomology and Malaria Control, Phnom Penh, Cambodia.
Dysoley LekNational Center for Parasitology, Entomology and Malaria Control, Phnom Penh, Cambodia.
Joanne M CunninghamUniversity of Notre Dame, Notre Dame, IN, USA.
Diane D LovinUniversity of Notre Dame, Notre Dame, IN, USA.
Nicholas W DanielUniversity of Notre Dame, Notre Dame, IN, USA.
Molly QuanUniversity of Notre Dame, Notre Dame, IN, USA.
Elodie VajdaMalaria Elimination Initiative, Institute for Global Health Sciences, University of California, San Francisco, USA.
Allison TatarskyMalaria Elimination Initiative, Institute for Global Health Sciences, University of California, San Francisco, USA.
Neil F LoboMalaria Elimination Initiative, Institute for Global Health Sciences, University of California, San Francisco, USA.

Funding

Amplicon deep sequencing (Amp-Seq) of malaria parasite genomes towards understanding forest transmission systemsR03AI158800 · NIAID · UNIVERSITY OF NOTRE DAME · PI LOBO, NEIL · 2021 to 2022
$173k
Innovative Vector Control Consortium A134328NIAID NIH HHS R03 AI158800NIH HHS 5RO3AI158800-02
6 · The paper itself

Abstract

backgroundMalaria, a mosquito-borne disease, is a serious public health issue globally and a leading cause of morbidity and mortality in many developing countries worldwide. Cambodia is in the last stages of malaria elimination and aims to eliminate all species of human malaria by 2025. Despite tremendous progress, eliminating malaria in Cambodia has proven to be challenging due to pockets of residual transmission in high-risk populations sustained by untreated asymptomatic malaria reservoirs. Understanding the extent of asymptomatic malaria reservoirs in 'last-mile' communities such as those in Mondulkiri and Kampong Speu, is vital for an effective malaria elimination strategy.

methodsMalaria cross-sectional surveys were conducted in high-risk populations (forest dwellers, forest goers and forest rangers) at three different time points (T0, T1, T2) from October 2022 to February 2023, overlapping the rainy, malaria transmission season and into the dry season. Blood samples (n = 6350) collected on filter paper from participants from all target groups were screened for Plasmodium species using qPCR.

resultsAll qPCR-diagnosed cases were asymptomatic, indicating an untreated parasite reservoir. In Mondulkiri, the prevalence of Plasmodium falciparum was 0.63% at T0, increasing to 0.81% at T1, and decreasing to 0.18% at T2. Plasmodium vivax decreased from 4.80% at T0 to 1.97% at T1 and 1.65% at T2. In Kampong Speu, overall prevalence was 7.06% at T0, declining to 5.19% at T1 and 4.59% at T2. Plasmodium falciparum prevalence was 0.30% at T0, decreasing to 0.09% at T1 and rising slightly to 0.10% at T2. The forest goers showed a prevalence increase to 1.95% at T1 and decrease to 1.46% by T2, while forest dwellers decreased to 3.25% at T1 and further to 3.13% at T2. Passively reported malaria case showed that 1.09% of cases in Mondulkiri and 0.21% of cases in Kampong Speu were rapid diagnostic test (RDT) positive.

conclusionEvidence generated during this study point to the continued presence of an untreated asymptomatic reservoir in high-risk populations. Targeted epidemiological and/or vector-based intervention strategies tailored to specific risk groups may enable a reduction of this sustaining reservoir of parasites, thereby leading to eliminating malaria in Cambodia.

Indexed as

Asymptomatic InfectionsDisease EradicationDisease ReservoirsMalariaMalaria, FalciparumMalaria, VivaxAdolescentAdultAgedCambodiaChildChild, PreschoolCross-Sectional StudiesFemaleHumansInfantAsymptomaticMalariaMalaria eliminationPlasmodiumPrevalenceQPCR

Identifiers

PMID40188335
PMCPMC11971876

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.